Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPA Acute Heart Failure
NCT03554200Phase 2Terminated
- Sponsor
- RWTH Aachen University
- Start
- Jun 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of empagliflozin in Acute Heart Failure (AHF), sponsored by RWTH Aachen University. Started Jun 2018; status: terminated.
02
Drugs
empagliflozin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT03554200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03554200.